跳至主要内容
临床试验/JPRN-UMIN000026220
JPRN-UMIN000026220已完成未知

Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy for pancreatic cancer - Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy

Second Department of Surgery, Wakayama Medical University0 个研究点目标入组 237 人开始时间: 2017年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
237

研究概览

简要总结

Mesenteric approach could reduce intraoperative blood loss volume in both resectable and borderline resectable (BR) PDAC during pancreaticoduodenectomy (PD). In resectable PDAC, mesenteric approach could increase R0 rate and improve the overall survival (OS), however, in BR PDAC, could not do them. Therefore, resectable PDAC has oncological benefits of mesenteric approach, however, only surgical method might not give the oncological benefit fo BR PDAC might.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • patients without pathological diagnosis of pancreatic ductal adenocarcinoma

研究者

发起方
Second Department of Surgery, Wakayama Medical University

相似试验